
New research reveals a promising strategy to slow type 1 diabetes progression by targeting inflammation with an existing psoriasis drug.

New research reveals a promising strategy to slow type 1 diabetes progression by targeting inflammation with an existing psoriasis drug.

In vitro studies demonstrated that retinoic acid aids stem cells in transitioning away from a state of flexibility in wound healing.